한글목차

창상관리 생물제제 시장 규모는 2025년 47억 달러에서 2034년에는 109억 2,000만 달러에 달할 것으로 예측되고 있으며, 2026-2034년에 CAGR 9.82%로 성장할 전망입니다.

상처 치료용 생물제제 시장은 첨단 상처 관리 솔루션에 대한 수요가 지속적으로 증가함에 따라 큰 폭의 성장이 예상됩니다. 성장인자, 피부 대체재, 세포치료제 등 생물 유래 제품을 포함한 상처 치료용 생물제제는 치유 촉진과 환자 예후 개선을 목적으로 점점 더 많이 활용되고 있습니다. 당뇨병성 궤양, 욕창 등 만성 상처의 유병률 증가와 더불어 고령화 사회의 진전은 생물학적 상처 관리 제품 수요를 견인하고 있습니다. 의료진이 상처 치유를 촉진하고 합병증을 줄이기 위해 노력함에 따라 상처 치료용 생물제제 시장은 확대될 것으로 예측됩니다.

기술 혁신은 상처 치료 생물제제 시장 전망를 형성하는 데 중요한 역할을 하고 있습니다. 조직공학과 재생의료의 발전으로 상처 치유를 촉진하고 피부의 완전성을 회복시키는 첨단 생물학적 제품들이 개발되고 있습니다. 또한 바이오소재와 나노테크놀러지의 통합으로 상처 치료 생물제제의 효과와 안전성이 향상되고 있습니다. 제조업체들이 연구개발에 대한 투자를 지속하는 가운데, 상처치료용 생물제제 시장은 병원, 외래진료소, 재택의료 등 다양한 의료현장에서 채용이 확대될 것으로 예측됩니다.

또한 맞춤형 의료와 환자 중심 치료에 대한 관심이 높아지면서 상처 치료용 생물제제 시장의 성장 궤도에 영향을 미치고 있습니다. 의료진이 환자 개개인의 필요에 맞는 상처 관리 치료의 중요성을 인식함에 따라 맞춤형 솔루션을 제공하는 생물제제에 대한 수요가 증가하고 있습니다. 이러한 추세에 따라 제조업체, 임상의사, 연구자 간의 협력을 통해 특정 환자 요구사항에 맞는 혁신적인 상처 치료용 생물제제를 개발하기 위한 노력이 진행되고 있습니다. 시장이 계속 진화하는 가운데, 기술 도입, 개인화, 환자 참여의 통합은 성공의 중요한 원동력이 될 것입니다.

목차

제1장 서론

제2장 개요

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 창상관리용 생물제제 시장 : 제품 유형별

제5장 세계의 창상관리용 생물제제 시장 : 용도별

제6장 세계의 창상관리용 생물제제 시장 : 최종사용자별

제7장 세계의 창상관리용 생물제제 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Wound Care Biologics Market size is expected to reach USD 10.92 Billion in 2034 from USD 4.70 Billion (2025) growing at a CAGR of 9.82% during 2026-2034.

The Wound Care Biologics Market is poised for significant growth as the demand for advanced wound management solutions continues to rise. Wound care biologics, which include products derived from living organisms, such as growth factors, skin substitutes, and cellular therapies, are increasingly being utilized to promote healing and improve patient outcomes. The rising prevalence of chronic wounds, such as diabetic ulcers and pressure sores, coupled with an aging population, is driving the demand for biologic wound care products. As healthcare providers seek to enhance wound healing and reduce complications, the market for wound care biologics is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the wound care biologics market. Innovations in tissue engineering and regenerative medicine are leading to the development of advanced biologic products that can accelerate wound healing and restore skin integrity. Additionally, the integration of biomaterials and nanotechnology is enhancing the efficacy and safety of wound care biologics. As manufacturers continue to invest in research and development, the wound care biologics market is likely to see increased adoption across various healthcare settings, including hospitals, outpatient clinics, and home healthcare.

Moreover, the growing emphasis on personalized medicine and patient-centered care is influencing the wound care biologics market's growth trajectory. As healthcare providers recognize the importance of tailoring wound care treatments to individual patient needs, there is a rising demand for biologic products that offer customizable solutions. This trend is driving collaboration between manufacturers, clinicians, and researchers to develop innovative wound care biologics that address specific patient requirements. As the market continues to evolve, the integration of technology, personalization, and patient engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Skin Substitutes
• Growth Factors
• Collagen-Based Products
• Others

By Application

• Chronic Wounds
• Acute Wounds
• Surgical Wounds
• Others

By End-User

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Smith Nephew, Organogenesis Inc, MiMedx Group Inc, Integra LifeSciences Corporation, Stryker Corporation, 3M Company, Mlnlycke Health Care AB, ConvaTec Group Plc, Coloplast AS, Johnson Johnson, Baxter International Inc, Derma Sciences Inc, Osiris Therapeutics Inc, Alliqua BioMedical Inc, Wright Medical Group NV

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL WOUND CARE BIOLOGICS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Skin Substitutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Growth Factors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Collagen-Based Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL WOUND CARE BIOLOGICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Chronic Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Acute Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Surgical Wounds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL WOUND CARE BIOLOGICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL WOUND CARE BIOLOGICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL WOUND CARE BIOLOGICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Smith & Nephew
  • 9.2.2 Organogenesis Inc
  • 9.2.3 MiMedx Group Inc
  • 9.2.4 Integra LifeSciences Corporation
  • 9.2.5 Stryker Corporation
  • 9.2.6 3M Company
  • 9.2.7 MA¶Lnlycke Health Care AB
  • 9.2.8 ConvaTec Group Plc
  • 9.2.9 Coloplast A/S
  • 9.2.10 Johnson & Johnson
  • 9.2.11 Baxter International Inc
  • 9.2.12 Derma Sciences Inc
  • 9.2.13 Osiris Therapeutics Inc
  • 9.2.14 Alliqua BioMedical Inc
  • 9.2.15 Wright Medical Group N.V